General Federal Contracts — June 21, 2026

Leidos Biomedical Research Inc. received a $1.78B obligation from HHS, the largest contract in this digest. The high materiality score (8/10) and bullish signal suggest this is a material revenue driver, though the lack of competition and pricing details limits margin analysis.

Bollinger Shipyards Lockport, L.L.C. was awarded a $1.26B contract from DHS, likely for Coast Guard vessel construction or maintenance. This is a significant civilian maritime award that could boost Bollinger's backlog, but the absence of competition data raises protest risk.

Both contracts lack pricing type (fixed-price vs. cost-plus) and competition data. For Leidos Biomedical's $1.78B HHS award, unknown pricing risk could mean lower margins if cost-plus. For Bollinger Shipyards' $1.26B DHS award, unknown competition could indicate a sole-source award vulnerable to protest.

The entire $3.04B digest is concentrated in two civilian agencies (HHS and DHS) with zero defense awards. This concentration exposes investors to civilian budget cycles, which may be more volatile than DOD spending under a CR.

The $1.78B Leidos Biomedical award signals strong HHS spending on biomedical research, potentially expanding Leidos' civilian revenue base beyond defense. This could reduce Leidos' reliance on DOD contracts and diversify its revenue stream.

Bollinger Shipyards' $1.26B DHS award for maritime assets could position the company for future DOD shipbuilding contracts, given the Navy's focus on fleet expansion. The contract may serve as a capability demonstration.

Both contracts are from civilian agencies (HHS and DHS), totaling $3.04B, with zero defense awards. This suggests a near-term shift in federal procurement focus toward health and homeland security, potentially at the expense of DOD spending.

The digest contains only two contracts, each exceeding $1B, with no small or medium-sized awards. This indicates a high concentration of federal spending in a few large programs, which can create volatility if one contract is protested or delayed.

{"entity"=>"Leidos Holdings Inc.", "reason"=>"Leidos Biomedical Research Inc. received a $1.78B HHS contract, which could be a material revenue contributor. The lack of competition data raises the need to watch for protest filings or re-compete announcements.", "trigger"=>"Option exercise date, re-compete announcement, or protest filing"}

{"entity"=>"Bollinger Shipyards", "reason"=>"Bollinger Shipyards Lockport won a $1.26B DHS contract. This is a large civilian maritime award that could face protest or budget cuts under a CR.", "trigger"=>"CR resolution, Coast Guard budget approval, protest deadline"}

{"entity"=>"Department of Health and Human Services", "reason"=>"HHS awarded the largest contract in this digest ($1.78B). Future HHS spending trends will impact Leidos and other biomedical contractors.", "trigger"=>"HHS budget appropriations, NDAA provisions for biomedical research"}